The Stem Cells theme has 11 member stock(s) today, with an average return of -1.1%. The leading stock is 네이처셀 (+1.0%, trading value 4,496,671,200).
Developers of stem cell therapeutics aimed at regenerating damaged tissues, attracting attention on positive clinical trial progress for intractable diseases.
| Stock | Price | Return | Trading Value |
|---|---|---|---|
| 네이처셀 | 25,350 | +1.0% | 4,496,671,200 |
| 동구바이오제약 | 3,510 | +0.3% | 80,621,861 |
| 풍전약품 | 2,345 | +0.2% | 31,559,510 |
| 테고사이언스 | 7,300 | -0.4% | 8,102,480 |
| 메디포스트 | 8,700 | -0.5% | 389,826,350 |
| 제일약품 | 10,020 | -0.8% | 124,929,760 |
| 차바이오텍 | 7,940 | -1.2% | 1,684,211,170 |
| 코아스템켐온 | 2,115 | -2.3% | 116,082,370 |
| 안트로젠 | 14,940 | -2.4% | 304,476,545 |
| 파미셀 | 10,960 | -2.7% | 5,416,748,045 |
| 엠젠솔루션 | 1,329 | -3.4% | 268,492,021 |
This page's data is for reference only and is not investment advice. Actual market data may differ.